High Content Screening Market is growing at a robust pace with Evotech Technologies launched Opera, a cell analyzer for fast high content analysis
High-content screening is a technique that is being used increasingly in drug discovery and preclinical research to identify materials like small molecules, proteins, or RNA which change the genetic output of the cells in the desired way. Cells that do not respond to a drug typically get filtered out because of their inability to absorb the drug, and therefore the scientist looking for a new one has to look elsewhere. This is why screenings are done frequently using high-activity substances like drugs for cancer, AIDS, and infectious diseases. When it comes to regional impact, North America is exhibiting a positive outlook in the high content screening market. This could be attributed to rising cases of chronic diseases and the rapidly growing geriatric population across the region. On the contrary, Asia Pacific is registering significant traction with growing disposable incomes across the region. The most common application for high content screening i...